Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of the Safety and Effectiveness of Levofloxacin Compared With Lomefloxacin in the Treatment of Complicated Urinary Tract Infections
This study has been completed.
Study NCT00258102   Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: November 22, 2005   Last Updated: May 11, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bacterial Infections
Urinary Tract Infections
Bacteriuria
Urologic Diseases
Additional conditions recognized in this trial
Communicable Diseases
Infection
Interventions listed in this trial
Levofloxacin
Additional drug interventions recognized in this trial
Anti-Infective Agents, Urinary
Lomefloxacin
Ofloxacin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Renal Agents
Therapeutic Uses
Sponsors listed in this trial
Johnson &Johnson Pharmaceutical Research &Development, L.L.C.
PriCara, Unit of Ortho-McNeil, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services